OMNIBUS AMENDMENT
Exhibit 4.5
THIS OMNIBUS AMENDMENT (the “Agreement”) is made and entered into as of August 25, 2009
between Alimera Sciences, Inc., a Delaware corporation (the “Company”) and each person or entity
identified as a “Stockholder” on the signature pages hereto (each a “Stockholder” and collectively,
the “Stockholders”).
RECITALS
WHEREAS, the Company proposes to issue shares of its Series C-1 Preferred Stock and warrants
to purchase shares of its Series C-1 Preferred Stock (the “Series C-1 Financing”) pursuant to the
terms and conditions of that certain Series C-1 Preferred Stock and Warrant Purchase Agreement of
even date herewith (the “Stock Purchase Agreement”);
WHEREAS, certain of the Stockholders are parties to each of (i) that certain Second Amended
and Restated Investor Rights Agreement, dated as of March 17, 2008, by and among the Company and
certain holders of the Company’s capital stock (the “Investor Rights Agreement”) and (ii) that
certain Second Amended and Restated Stock Sale Agreement, dated as of March 17, 2008, by and among
the Company and certain holders of the Company’s capital stock (the “Stock Sale Agreement”);
WHEREAS, pursuant to Section 7.5 of the Investor Rights Agreement, any term of the Investor
Rights Agreement may be amended with the written consent of the Company and the Investors holding
at least two-thirds (2/3) of the shares of Investor Stock (as defined therein), voting together as
a single group, and including, for such purposes, shares of Common Stock into which any shares of
Investor Stock have been converted (collectively, the “XXX Requisite Parties”);
WHEREAS, pursuant to Section 9.3 of the Stock Sale Agreement, any term of the Stock Sale
Agreement may be amended with the written consent of the Company, the holders of at least a
majority of the then outstanding Common Stock held by the Common Holders then providing services to
the Company as an officer, employee or consultant, and the holders of at least a majority of the
then outstanding Preferred Stock held by the Investors (each as defined therein) (collectively, the
“Stock Sale Agreement Requisite Parties”);
WHEREAS, Dr. Xxxxxx Xxxxxxx is an Eligible Holder (as defined in the Investor Rights
Agreement) with a right to purchase his Pro Rata Share (as defined in the Investor Rights
Agreement) of Series C-1 Units issued by the Company in the Series C-1 Financing;
WHEREAS, Xx. Xxxxxxx desires to assign such right to purchase Series C-1 Units to the Xxxxxx
X. Xxxxxxx MD PC Pension Plan (the “Xxxxxxx Pension Plan”), such that the Xxxxxxx Pension Plan
shall purchase Series C-1 Units issued pursuant to the Stock Purchase Agreement in the Series C-1
Financing; provided, however, that as a condition with such purchase, the Xxxxxxx Pensions Plan
shall become a party to each of the Investor Rights Agreement and the Stock Sale Agreement; and
WHEREAS, in connection with the Series C-1 Financing, the Company and the undersigned
Stockholders, constituting both the XXX Requisite Parties and the Stock Sale
Agreement Requisite Parties, desire to amend the Investor Rights Agreement and the Stock Sale
Agreement as set forth herein and to consent to the admission of the Xxxxxxx Pension Plan as a
party to each such agreement.
AGREEMENT
NOW, THEREFORE, in consideration of the promises and conditions contained herein, and other
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereby agree as follows:
1. | Amendment of Investor Rights Agreement. Upon execution of this Agreement by the XXX Requisite Parties, the Investor Rights Agreement shall be amended as follows: |
a. | A new exhibit, in the form attached hereto as Attachment 1, shall be added to the Investor Rights Agreement as Exhibit F thereto. |
b. | The parties to the Investor Rights Agreement shall be deemed to include the investors listed on Exhibit F thereto (as attached by operation hereof), which such parties shall be referred to for purposes of such agreement as the “Series C-1 Investors”. The definition of “Investors” therein shall be amended to include such Series C-1 Investors. |
c. | The definition of “Investor Stock” shall be amended to include shares of the Company’s Series C-1 Preferred Stock, par value $0.01 per share, including shares issued or issuable upon exercise of warrants exercisable therefor. |
2. | Amendment of Stock Sale Agreement. Upon execution of this Agreement by the Stock Sale Requisite Parties, the Stock Sale Agreement shall be amended as follows: |
a. | A new exhibit, in the form attached hereto as Attachment 1, shall be added to the Stock Sale Agreement as Exhibit E thereto. |
b. | The parties to the Stock Sale Agreement shall be deemed to include the investors listed on Exhibit E thereto (as attached by operation hereof), which such parties shall be referred to for purposes of such agreement as the “Series C-1 Investors”. The definition of each of “Investors” and “Stockholders” shall be amended to include such Series C-1 Investors. |
c. | The definition of “Preferred Stock” shall be amended to include shares of the Company’s Series C-1 Preferred Stock, par value $0.01 per share, including shares issued or issuable upon exercise of warrants exercisable therefor. |
3. | Xxxxxxx Pension Plan. |
a. | By its signature below, the Xxxxxxx Pension Plan hereby agrees, effective as of the date hereof, to be bound by and to become party to the Investor Rights Agreement and the Stock Sale Agreement, each as may be amended from time to time (including, without limitation, by this Agreement), in each case as a “Series C-1 Investor”. The Xxxxxxx Pension Plan further acknowledges that its signature page attached to this agreement shall be deemed a counterpart signature page to each of the Investor Rights Agreement and the Stock Sale Agreement and, as such, may be attached to each such agreement. |
b. | Each Stockholder hereby consents to the assignment by Xx. Xxxxxxx of his right under the Investor Rights Agreement to purchase Series C-1 Units to the Xxxxxxx Pension Plan; provided, however, that such consent is expressly conditioned on the execution and delivery by the Xxxxxxx Pension Plan of this Agreement. |
c. | Upon execution of this Agreement by each of (i) the XXX Requisite Parties, (ii) the Stock Sale Agreement Requisite Parties and (iii) the Xxxxxxx Pension Plan, each of Investor Rights Agreement and the Stock Sale Agreement shall be amended to include the Xxxxxxx Pension Plan as a party thereto, in each case as a “Series C-1 Investor”. |
4. | General. |
a. | Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties hereto. |
b. | Except as expressly provided herein, all provisions of each of the Investor Rights Agreement and the Stock Sale Agreement shall remain in full force and effect. |
c. | This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to Delaware conflict of law principles. |
d. | This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. |
IN WITNESS WHEREOF, this Omnibus Amendment has been duly executed and delivered by the parties
as of the date first above written.
COMPANY: | ||||||
ALIMERA SCIENCES, INC. | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
IN WITNESS WHEREOF, this Omnibus Amendment has been duly executed and delivered by the parties
as of the date first above written.
STOCKHOLDER: | ||||||
Dr. Xxxxxx Xxxxxxx | ||||||
XXXXXXX PENSION PLAN: | ||||||
XXXXXX X. XXXXXXX MD PC PENSION PLAN | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
IN WITNESS WHEREOF, this Omnibus Amendment has been duly executed and delivered by the parties
as of the date first above written.
STOCKHOLDERS: | ||||||
VENROCK PARTNERS, L.P. | ||||||
by its General Partner, Venrock Partners | ||||||
Management, LLC | ||||||
VENROCK ASSOCIATES IV, L.P. by its General Partner, Venrock Management IV, LLC |
||||||
VENROCK ENTREPRENEURS FUND IV, L.P. | ||||||
by its General Partner, VEF Management IV, LLC | ||||||
By: | ||||||
Name: | ||||||
Title: |
IN WITNESS WHEREOF, this Omnibus Amendment has been duly executed and delivered by the parties
as of the date first above written.
STOCKHOLDERS: | ||||||
INTERSOUTH PARTNERS VII, L.P. | ||||||
By: | Intersouth Associates VII, L.P., its General Partner |
|||||
By: | ||||||
Name: Xxxxxx Xxxxx | ||||||
Title: Member, acting pursuant to Power of Attorney | ||||||
INTERSOUTH PARTNERS V, L.P. | ||||||
By: | Intersouth Associates V, L.P., its General Partner |
|||||
By: | ||||||
Name: Xxxxxx Xxxxx | ||||||
Title: Member, acting pursuant to Power of Attorney | ||||||
INTERSOUTH AFFILIATES V, L.P. | ||||||
By: | Intersouth Associates V, LLC, | |||||
its General Partner | ||||||
By: | ||||||
Name: Xxxxxx Xxxxx | ||||||
Title: Member, acting pursuant to Power of Attorney |
IN WITNESS WHEREOF, this Omnibus Amendment has been duly executed and delivered by the parties
as of the date first above written.
STOCKHOLDERS: | ||||||
INTERSOUTH PARTNERS VI, L.P. | ||||||
By: | Intersouth Associates VI, LLC, | |||||
its General Partner | ||||||
By: | ||||||
Name: Xxxxxx Xxxxx | ||||||
Title: Member, acting pursuant to Power of Attorney |
Signature Page to
Alimera Sciences, Inc.
Omnibus Amendment
Alimera Sciences, Inc.
Omnibus Amendment
IN WITNESS WHEREOF, this Omnibus Amendment has been duly executed and delivered by the parties
as of the date first above written.
STOCKHOLDERS: | ||||||
BAVP, L.P. | ||||||
By: | Scale Venture Management I, LLC | |||||
Its: | general partner | |||||
Name: Xxxx Xxxxxx | ||||||
Title: Managing Director |
Signature Page to
Alimera Sciences, Inc.
Omnibus Amendment
Alimera Sciences, Inc.
Omnibus Amendment
IN WITNESS WHEREOF, this Omnibus Amendment has been duly executed and delivered by the parties
as of the date first above written.
STOCKHOLDERS: | ||||||
POLARIS VENTURE PARTNERS IV, L.P. | ||||||
By: | Polaris Venture Management Co. IV, L.L.C., | |||||
its General Partner | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
POLARIS VENTURE PARTNERS ENTREPRENEURS’ FUND IV, L.P. | ||||||
By: | Polaris Venture Management Co. IV, L.L.C., | |||||
its General Partner | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
Signature Page to
Alimera Sciences, Inc.
Omnibus Amendment
Alimera Sciences, Inc.
Omnibus Amendment
IN WITNESS WHEREOF, this Omnibus Amendment has been duly executed and delivered by the parties
as of the date first above written.
STOCKHOLDERS: | ||||||
DOMAIN PARTNERS VI, L.P. | ||||||
By: | One Xxxxxx Square Associates VI, L.L.C., | |||||
its General Partner | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
DP VI ASSOCIATES, L.P. | ||||||
By: | One Xxxxxx Square Associates VI, L.L.C., | |||||
its General Partner | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
Signature Page to
Alimera Sciences, Inc.
Omnibus Amendment
Alimera Sciences, Inc.
Omnibus Amendment
IN WITNESS WHEREOF, this Omnibus Amendment has been duly executed and delivered by the parties
as of the date first above written.
STOCKHOLDERS: | ||||||
G&H PARTNERS | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
Signature Page to
Alimera Sciences, Inc.
Omnibus Amendment
Alimera Sciences, Inc.
Omnibus Amendment
IN WITNESS WHEREOF, this Omnibus Amendment has been duly executed and delivered by the parties
as of the date first above written.
STOCKHOLDERS: | ||||
Signature Page to
Alimera Sciences, Inc.
Omnibus Amendment
Alimera Sciences, Inc.
Omnibus Amendment
Attachment 1
Series C-1 Investors
Series C-1 Shares | ||||||||
Series C-1 Closing | Issuable upon | |||||||
Name of Investor | Shares | Warrant Exercise | ||||||
Venrock Associates IV, L.P. |
429,125 | 858,250 | ||||||
Venrock Entrepreneurs’ Fund IV, L.P. |
10,544 | 21,088 | ||||||
Venrock Partners, L.P. |
87,512 | 175,024 | ||||||
Intersouth Partners VII, L.P. |
421,257 | 842,514 | ||||||
Intersouth Partners V, L.P. |
219,787 | 439,574 | ||||||
Intersouth Affiliates V, L.P. |
10,074 | 20,148 | ||||||
BAVP, L.P. |
651,118 | 1,302,236 | ||||||
Domain Partners VI, L.P. |
644,214 | 1,288,428 | ||||||
DP VI Associates, L.P. |
6,904 | 13,808 | ||||||
Polaris Venture Partners IV, L.P. |
639,425 | 1,278,850 | ||||||
Polaris Venture Partners
Entrepreneurs’ Fund IV, L.P. |
11,693 | 23,386 | ||||||
The Xxxxxx X. Xxxxxxx MD PC Pension
Plan |
46,000 | 92,000 | ||||||
Xxxxxx Xxx Xxxxx |
543 | 1,086 | ||||||
REDLOH Capital, LLC |
4,857 | 9,714 | ||||||
BFG Investments LLC |
12,960 | 25,920 | ||||||
Xxxxxx X. Xxxxxxx, Xx. |
4,828 | 9,656 | ||||||
C&B Capital II, L.P. |
35,355 | 70,710 | ||||||
C&B Capital II (PF), L.P. |
29,020 | 58,040 |
Series C-1 Shares | ||||||||
Series C-1 Closing | Issuable upon | |||||||
Name of Investor | Shares | Warrant Exercise | ||||||
Xxxxx Xxxxxx |
1,107 | 2,214 | ||||||
Xxxxxx Xxxxxx |
543 | 1,086 | ||||||
Xxxxx X. and Xxxxx X. Xxxx |
7,818 | 15,636 | ||||||
Xxxxxx X. Xxxx |
1,201 | 2,402 | ||||||
Xxxxxxx X. Xxxx |
1,201 | 2,402 | ||||||
Xxxxxxxx Family LP |
3,622 | 7,244 | ||||||
G&H Partners |
10,000 | 20,000 |